July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Supriya Peshin: FDA Approved Retifanlimab Combination for 1st Line Treatment of Advanced SCAC
May 30, 2025, 14:45

Supriya Peshin: FDA Approved Retifanlimab Combination for 1st Line Treatment of Advanced SCAC

Supriya Peshin, Visiting Resident in Hematology and Oncology at MD Anderson Cancer Center, shared a post on X:

“Learned something new today in GI Oncclinic MD Anderson Cancer Center: FDA approved retifanlimab +carboplatin/paclitaxel for first-line treatment of advanced SCAC major step forward in care for Anal cancer.”

Read Full Blog on FDA.

Read More on OncoDaily’s special article: “FDA Approves Retifanlimab-dlwr with Chemotherapy and as Monotherapy for Advanced Squamous Cell Carcinoma of the Anal Canal

Retifanlimab-dlwr FDA approval on OncoDaily FDA Approved